Switzerland heads towards cannabis legalisation, but some hurdles remain

Switzerland inched closer towards legalising recreational and medical cannabis as a committee of the upper parliamentary chamber backed a proposal to regulate the market. But it could be years before the country creates such a regulated cannabis market.

The Council of States’ health commission voted 9-2 on 19th October in favour of an initiative by national councillor Heinz Siegenthaler to introduce a bill reforming Swiss drug policy. Forty parliamentarians across all political groups have also co-signed the initiative. The health commission of the National Council – the lower house of Parliament – supported the plan in April, so the proposal now goes back to the full assembly, which is likely to approve it and start work in 2022. A draft decree should be drawn up within two years.

Read full article
I'm already a subscriber
Author default picture

CannIntelligence

This article was written by one of CannIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual cannabis and cannabinoid markets. For a full list, please see our Who We Are page.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization